-
1
-
-
2342590729
-
French field experience with buprenorphine
-
Auriacombe M., Fatseas M., Dubernet J., Daulouede J.P., Tignol J. French field experience with buprenorphine. The American Journal on Addictions 2004, 13(Suppl. 1):S17-S28.
-
(2004)
The American Journal on Addictions
, vol.13
, Issue.SUPPL. 1
-
-
Auriacombe, M.1
Fatseas, M.2
Dubernet, J.3
Daulouede, J.P.4
Tignol, J.5
-
2
-
-
84883667330
-
-
Baltimore Substance Abuse Systems, Baltimore City Health Department, Baltimore City Health Department Data Snapshot, Baltimore, Maryland
-
Baltimore Substance Abuse Systems, Baltimore City Health Department Drug treatment in Baltimore: 2005 2006, Baltimore City Health Department Data Snapshot, Baltimore, Maryland.
-
(2006)
Drug treatment in Baltimore: 2005
-
-
-
4
-
-
79954515756
-
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users
-
Bazazi A.R., Yokell M., Fu J.J., Rich J.D., Zaller N.D. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. Journal of Addiction Medicine 2011, 5(3):175-180.
-
(2011)
Journal of Addiction Medicine
, vol.5
, Issue.3
, pp. 175-180
-
-
Bazazi, A.R.1
Yokell, M.2
Fu, J.J.3
Rich, J.D.4
Zaller, N.D.5
-
5
-
-
77955406807
-
The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective
-
Bell J. The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective. Addiction 2010, 105(9):1531-1537.
-
(2010)
Addiction
, vol.105
, Issue.9
, pp. 1531-1537
-
-
Bell, J.1
-
6
-
-
67651122922
-
Comparing overdose mortality associated with methadone and buprenorphine treatment
-
Bell J.R., Butler B., Lawrance A., Batey R., Salmelainen P. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug and Alcohol Dependence 2009, 104:73-77.
-
(2009)
Drug and Alcohol Dependence
, vol.104
, pp. 73-77
-
-
Bell, J.R.1
Butler, B.2
Lawrance, A.3
Batey, R.4
Salmelainen, P.5
-
7
-
-
42549111760
-
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002
-
Brady J.E., Friedman S.R., Cooper H.L., Flom P.L., Tempalski B., Gostnell K. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2008, 85(3):323-351.
-
(2008)
Journal of Urban Health: Bulletin of the New York Academy of Medicine
, vol.85
, Issue.3
, pp. 323-351
-
-
Brady, J.E.1
Friedman, S.R.2
Cooper, H.L.3
Flom, P.L.4
Tempalski, B.5
Gostnell, K.6
-
8
-
-
27244452980
-
Potential for abuse of buprenorphine in office-based treatment of opioid dependence
-
Cicero T.J., Inciardi J.A. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. The New England Journal of Medicine 2005, 353(17):1863-1865.
-
(2005)
The New England Journal of Medicine
, vol.353
, Issue.17
, pp. 1863-1865
-
-
Cicero, T.J.1
Inciardi, J.A.2
-
9
-
-
77955165148
-
Post-marketing surveillance of methadone and buprenorphine in the United States
-
Dasgupta N., Bailey E.J., Cicero T., Inciardi J., Parrino M., Rosenblum A., et al. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Medicine 2010, 11(7):1078-1091.
-
(2010)
Pain Medicine
, vol.11
, Issue.7
, pp. 1078-1091
-
-
Dasgupta, N.1
Bailey, E.J.2
Cicero, T.3
Inciardi, J.4
Parrino, M.5
Rosenblum, A.6
-
10
-
-
36749009166
-
Prescription opioid use, misuse, and diversion among street drug users in New York City
-
Davis W.R., Johnson B.D. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence 2008, 92:267-276.
-
(2008)
Drug and Alcohol Dependence
, vol.92
, pp. 267-276
-
-
Davis, W.R.1
Johnson, B.D.2
-
11
-
-
84883689903
-
-
Drug Addiction Treatment Act of 2000 (DATA)
-
Drug Addiction Treatment Act of 2000 (DATA) Title XXXV, section 3502 2000.
-
(2000)
Title XXXV, section 3502
-
-
-
12
-
-
41949128212
-
Long-term treatment with buprenorphine/naloxone in primary care: Results at 2-5years
-
Fiellin D.A., Moore B.A., Sullivan L.E., Becker W.C., Pantalon M.V., Chawarski M.C., et al. Long-term treatment with buprenorphine/naloxone in primary care: Results at 2-5years. The American Journal on Addictions 2008, 17(2):116-120.
-
(2008)
The American Journal on Addictions
, vol.17
, Issue.2
, pp. 116-120
-
-
Fiellin, D.A.1
Moore, B.A.2
Sullivan, L.E.3
Becker, W.C.4
Pantalon, M.V.5
Chawarski, M.C.6
-
13
-
-
4344633903
-
Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users
-
Friedman S.R., Tempalski B., Cooper H., Perlis T., Keem M., Friedman R., et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2004, 81(3):377-400.
-
(2004)
Journal of Urban Health: Bulletin of the New York Academy of Medicine
, vol.81
, Issue.3
, pp. 377-400
-
-
Friedman, S.R.1
Tempalski, B.2
Cooper, H.3
Perlis, T.4
Keem, M.5
Friedman, R.6
-
14
-
-
0042360208
-
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
-
Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. The New England Journal of Medicine 2003, 10:949-958.
-
(2003)
The New England Journal of Medicine
, vol.10
, pp. 949-958
-
-
Fudala, P.J.1
Bridge, T.P.2
Herbert, S.3
Williford, W.O.4
Chiang, C.N.5
Jones, K.6
-
15
-
-
0141732110
-
Longitudinal patterns of drug injection behavior in the ALIVE study cohort,1988-2000: Description and determinants
-
Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D.D. Longitudinal patterns of drug injection behavior in the ALIVE study cohort,1988-2000: Description and determinants. American Journal of Epidemiology 2003, 158(7):695-704.
-
(2003)
American Journal of Epidemiology
, vol.158
, Issue.7
, pp. 695-704
-
-
Galai, N.1
Safaeian, M.2
Vlahov, D.3
Bolotin, A.4
Celentano, D.D.5
-
16
-
-
79953895443
-
Trajectories of injection drug use over 20years (1988-2008) in Baltimore, Maryland
-
Genberg B.L., Gange S.J., Go V.F., Celentano D.D., Kirk G.D., Mehta S.H. Trajectories of injection drug use over 20years (1988-2008) in Baltimore, Maryland. American Journal of Epidemiology 2011, 173(7):829-836.
-
(2011)
American Journal of Epidemiology
, vol.173
, Issue.7
, pp. 829-836
-
-
Genberg, B.L.1
Gange, S.J.2
Go, V.F.3
Celentano, D.D.4
Kirk, G.D.5
Mehta, S.H.6
-
17
-
-
70449604853
-
Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland
-
Gwin Mitchell S., Kelly S.M., Brown B.S., Schacht Reisinger H., Peterson J.A., Ruhf A., et al. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions 2009, 18(5):346-355.
-
(2009)
The American Journal on Addictions
, vol.18
, Issue.5
, pp. 346-355
-
-
Gwin Mitchell, S.1
Kelly, S.M.2
Brown, B.S.3
Schacht Reisinger, H.4
Peterson, J.A.5
Ruhf, A.6
-
19
-
-
84155164697
-
Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians
-
Johanson C.E., Arfken C.L., di Menza S., Schuster C.R. Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians. Drug and Alcohol Dependence 2011, 120(1-3):190-195.
-
(2011)
Drug and Alcohol Dependence
, vol.120
, Issue.1-3
, pp. 190-195
-
-
Johanson, C.E.1
Arfken, C.L.2
di Menza, S.3
Schuster, C.R.4
-
20
-
-
0034597736
-
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
-
Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. The New England Journal of Medicine 2000, 343(18):1290-1297.
-
(2000)
The New England Journal of Medicine
, vol.343
, Issue.18
, pp. 1290-1297
-
-
Johnson, R.E.1
Chutuape, M.A.2
Strain, E.C.3
Walsh, S.L.4
Stitzer, M.L.5
Bigelow, G.E.6
-
22
-
-
0031850177
-
Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users
-
Latkin C.A., Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998, 93(8):1191-1197.
-
(1998)
Addiction
, vol.93
, Issue.8
, pp. 1191-1197
-
-
Latkin, C.A.1
Vlahov, D.2
-
23
-
-
0027403473
-
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users
-
Latkin C.A., Vlahov D., Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993, 88(4):517-526.
-
(1993)
Addiction
, vol.88
, Issue.4
, pp. 517-526
-
-
Latkin, C.A.1
Vlahov, D.2
Anthony, J.C.3
-
24
-
-
15444361736
-
Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial
-
Ling W., Charuvastra C., Collins J.F., Batki S., Brown L.S., Kintaudi P., et al. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction 1998, 93(4):475-486.
-
(1998)
Addiction
, vol.93
, Issue.4
, pp. 475-486
-
-
Ling, W.1
Charuvastra, C.2
Collins, J.F.3
Batki, S.4
Brown, L.S.5
Kintaudi, P.6
-
25
-
-
0037394666
-
Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients
-
Mattick R.P., Ali R., White J.M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003, 98(4):441-452.
-
(2003)
Addiction
, vol.98
, Issue.4
, pp. 441-452
-
-
Mattick, R.P.1
Ali, R.2
White, J.M.3
O'Brien, S.4
Wolk, S.5
Danz, C.6
-
26
-
-
0023726538
-
Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys
-
Mello N.K., Lukas S.E., Bree M.P., Mendelson J.H. Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys. Drug and Alcohol Dependence 1988, 21(2):81-97.
-
(1988)
Drug and Alcohol Dependence
, vol.21
, Issue.2
, pp. 81-97
-
-
Mello, N.K.1
Lukas, S.E.2
Bree, M.P.3
Mendelson, J.H.4
-
28
-
-
70449652165
-
Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence
-
Monte A.A., Mandell T., Wilford B.B., Tennyson J., Boyer E.W. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. Journal of Addictive Diseases 2009, 28(3):226-231.
-
(2009)
Journal of Addictive Diseases
, vol.28
, Issue.3
, pp. 226-231
-
-
Monte, A.A.1
Mandell, T.2
Wilford, B.B.3
Tennyson, J.4
Boyer, E.W.5
-
29
-
-
84883733212
-
-
Office of Epidemiology and Planning, Baltimore City Health Department, Baltimore City Health Department, Baltimore, Maryland
-
Office of Epidemiology and Planning, Baltimore City Health Department Intoxication deaths associated with drugs of abuse or alcohol 2007, Baltimore City Health Department, Baltimore, Maryland.
-
(2007)
Intoxication deaths associated with drugs of abuse or alcohol
-
-
-
30
-
-
7444264525
-
A critical review of the causes of death among post-mortem toxicological investigations: Analysis of 34 buprenorphine-associated and 35 methadone-associated deaths
-
Pirnay S., Borron S.W., Giudicelli C.P., Tourneau J., Baud F.J., Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: Analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004, 99(8):978-988.
-
(2004)
Addiction
, vol.99
, Issue.8
, pp. 978-988
-
-
Pirnay, S.1
Borron, S.W.2
Giudicelli, C.P.3
Tourneau, J.4
Baud, F.J.5
Ricordel, I.6
-
32
-
-
77953614918
-
Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers
-
Schuman-Olivier Z., Albanese M., Nelson S.E., Roland L., Puopolo F., Klinker L., et al. Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers. Journal of Substance Abuse Treatment 2010, 39(1):41-50.
-
(2010)
Journal of Substance Abuse Treatment
, vol.39
, Issue.1
, pp. 41-50
-
-
Schuman-Olivier, Z.1
Albanese, M.2
Nelson, S.E.3
Roland, L.4
Puopolo, F.5
Klinker, L.6
-
33
-
-
33746617377
-
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000
-
Shah N.G., Galai N., Celentano D.D., Vlahov D., Strathdee S.A. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug and Alcohol Dependence 2006, 83(2):147-156.
-
(2006)
Drug and Alcohol Dependence
, vol.83
, Issue.2
, pp. 147-156
-
-
Shah, N.G.1
Galai, N.2
Celentano, D.D.3
Vlahov, D.4
Strathdee, S.A.5
-
34
-
-
34548433490
-
Abuse of buprenorphine in the United States: 2003-2005
-
Smith M.Y., Bailey J.E., Woody G.E., Kleber H.D. Abuse of buprenorphine in the United States: 2003-2005. Journal of Addictive Diseases 2007, 26(3):107-111.
-
(2007)
Journal of Addictive Diseases
, vol.26
, Issue.3
, pp. 107-111
-
-
Smith, M.Y.1
Bailey, J.E.2
Woody, G.E.3
Kleber, H.D.4
-
35
-
-
44349097414
-
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
-
Sullivan L.E., Moore B.A., Chawarski M.C., Pantalon M.V., Barry D., O'Connor P.G., et al. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Journal of Substance Abuse Treatment 2008, 35(1):87-92.
-
(2008)
Journal of Substance Abuse Treatment
, vol.35
, Issue.1
, pp. 87-92
-
-
Sullivan, L.E.1
Moore, B.A.2
Chawarski, M.C.3
Pantalon, M.V.4
Barry, D.5
O'Connor, P.G.6
-
36
-
-
0347927456
-
Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France
-
Vidal-Trecan G., Varescon I., Nabet N., Boissonnas A. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug and Alcohol Dependence 2003, 69(2):175-181.
-
(2003)
Drug and Alcohol Dependence
, vol.69
, Issue.2
, pp. 175-181
-
-
Vidal-Trecan, G.1
Varescon, I.2
Nabet, N.3
Boissonnas, A.4
-
37
-
-
0026357723
-
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants
-
Vlahov D., Anthony J.C., Munoz A., Margolick J., Nelson K.E., Celentano D.D., et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monograph 1991, 109:75-100.
-
(1991)
NIDA Research Monograph
, vol.109
, pp. 75-100
-
-
Vlahov, D.1
Anthony, J.C.2
Munoz, A.3
Margolick, J.4
Nelson, K.E.5
Celentano, D.D.6
-
38
-
-
34247391051
-
Risk factors for methadone outside treatment programs: Implications for HIV treatment among injection drug users
-
Vlahov D., O'Driscoll P., Mehta S.H., Ompad D.C., Gern R., Galai N., et al. Risk factors for methadone outside treatment programs: Implications for HIV treatment among injection drug users. Addiction 2007, 102(Suppl. 1):771-777.
-
(2007)
Addiction
, vol.102
, Issue.SUPPL. 1
, pp. 771-777
-
-
Vlahov, D.1
O'Driscoll, P.2
Mehta, S.H.3
Ompad, D.C.4
Gern, R.5
Galai, N.6
-
39
-
-
0037987962
-
The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic
-
Walsh S.L., Eissenberg T. The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic. Drug and Alcohol Dependence 2003, 70(2 Suppl):S13-S27.
-
(2003)
Drug and Alcohol Dependence
, vol.70
, Issue.2 SUPPL.
-
-
Walsh, S.L.1
Eissenberg, T.2
-
40
-
-
0029070494
-
Acute administration of buprenorphine in humans: Partial agonist and blockade effects
-
Walsh S.L., Preston K.L., Bigelow G.E., Stitzer M.L. Acute administration of buprenorphine in humans: Partial agonist and blockade effects. The Journal of Pharmacology and Experimental Therapeutics 1995, 274(1):361-372.
-
(1995)
The Journal of Pharmacology and Experimental Therapeutics
, vol.274
, Issue.1
, pp. 361-372
-
-
Walsh, S.L.1
Preston, K.L.2
Bigelow, G.E.3
Stitzer, M.L.4
-
41
-
-
0028318472
-
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
-
Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., Bigelow G.E. Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology and Therapeutics 1994, 55(5):569-580.
-
(1994)
Clinical Pharmacology and Therapeutics
, vol.55
, Issue.5
, pp. 569-580
-
-
Walsh, S.L.1
Preston, K.L.2
Stitzer, M.L.3
Cone, E.J.4
Bigelow, G.E.5
|